References
- Brinton R D. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Ann N Y Acad Sci 2005; 1052: 57–74
- Henderson V W. Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research. Neuroscience 2006; 138: 1031–1039
- Genazzani A R, Pluchino N, Luisi S, Luisi M. Estrogen, cognition and female ageing. Hum Reprod Update 2007; 13: 175–187
- Mulnard R A. Methodological issues in estrogen treatment trials for Alzheimer's disease. Ann N Y Acad Sci 2005; 1052: 173–181
- Ishunina T A, van Beurden D, van der Meulen G, Unmehopa U A, Hol E M, Huitinga I, Swaab D F. Diminished aromatase immunoreactivity in the hypothalamus, but not in the basal forebrain nuclei in Alzheimer's disease. Neurobiol Aging 2005; 26: 173–194
- Ishunina T A, Fischer D F, Swaab D F. Estrogen receptor α and its splice variants in the hippocampus in aging and Alzheimer's disease. Neurobiol Aging 2007; 28: 1670–1681
- van Dijk M AJ, Hart A AM, van't Veer L J. Differences in estrogen receptor α variant messenger RNAs between normal human breast tissue and primary breast carcinomas. Cancer Res 2000; 60: 530–533
- Fasco M J, Hurteau G J, Spivack S D. Gender-dependent expression of α and β estrogen receptors in human nontumor and tumor lung tissue. Mol Cell Endocrinol 2002; 188: 125–140
- Flouriot G, Brand H, Seraphin B, Gannon F. Natural trans-spliced mRNAs are generated from the human estrogen receptor-α (hERα) gene. J Biol Chem 2002; 277: 26244–26251
- Poola I, Speirs V. Expression of alternatively spliced estrogen receptor α mRNAs is increased in breast cancer tissues. J Steroid Biochem Mol Biol 2001; 78: 459–469
- Fasco M J. Quantitation of estrogen receptor mRNA and its alternatively spliced mRNAs in breast tumor cells and tissues. Anal Biochem 1997; 245: 167–178
- Poola I, Koduri S, Chatra S, Clarke R. Identification of twenty alternatively spliced estrogen receptor α mRNAs in the breast cancer cell lines and tumors using spliced targeted primer approach. J Steroid Biochem Mol Biol 2000; 72: 249–258
- Flouriot G, Griffin C, Kenealy M, Sonntag-Buck V, Gannon F. Differentially expressed messenger RNA isoforms of the human estrogen receptor-α gene are generated by alternative splicing and promoter usage. Mol Endocrinol 1998; 12: 1939–1954
- Perlman W R, Matsumoto M, Beltaifa S, Hyde T M, Saunders R C, Webster M J, Rubinow D R, Kleinman J E, Weickert C S. Expression of estrogen receptor α exon-deleted mRNA variants in the human and non-human primate frontal cortex. Neuroscience 2005; 134: 81–95
- Poola I. Molecular assay to generate expression profile of eight estrogen receptor α isoform mRNA copy numbers in picogram amounts of total RNA from breast cancer tissues. Anal Biochem 2003; 314: 217–226
- Hirata S, Shoda T, Kato J, Hoshi K. Isoform/variant mRNAs for sex steroid hormone receptors in humans. Trends Endocrinol Metab 2003; 14: 124–129
- Ferro P, Forlani A, Muselli M, Pfeffer U. Alternative splicing of the human estrogen receptor α primary transcript: mechanisms of exon skipping. Int J Mol Med 2003; 12: 355–363
- Bollig A, Miksicek R J. An estrogen receptor-α splicing variant mediates both positive and negative effects on gene transcription. Mol Endocrinol 2000; 14: 634–649
- García Pedrero J M, Zuazua P, Martínez-Campa C, Lazo P S, Ramos S. The naturally occurring variant of estrogen receptor (ER) ERΔE7 suppresses estrogen-dependent transcriptional activation by both wild type ERα and ERβ. Endocrinology 2003; 144: 2967–2976
- Okuda Y, Hirata S, Watanabe N, Shoda T, Kato J, Hoshi K. Novel splicing events of untranslated first exons in human estrogen receptor α (ERα) gene. Endocr J 2003; 50: 97–104
- Pajares M, Ezponda T, Catena R, Calvo A, Pio R, Montuenga L M. Alternative splicing: an emerging topic in molecular and clinical oncology. Lancet Oncol 2007; 8: 349–357
- Yeo G, Holste D, Kreiman G, Burge C B. Variation in alternative splicing across human tissues. Genome Biology 2004; 5: R74.1–R74.15
- Meshorer E, Soreq H. Pre-mRNA splicing modulations in senescence. Aging Cell 2002; 1: 10–16
- Swaab D F. The human hypothalamus: basic and clinical aspects. Part I. Nuclei of the human hypothalamus. Handbook of clinical neurology, M J Aminoff, F Boller, D F Swaab. Elsevier, Amsterdam 2003; 502, Vol. 79, 3rd series, vol. 1
- Swaab D F. The human hypothalamus: basic and clinical aspects. Part II. Neuropathology of the human hypothalamus and adjacent structures. Handbook of clinical neurology, M J Aminoff, F Boller, D F Swaab. Elsevier, Amsterdam 2004; 632, Vol. 80, 3rd series, vol. 2
- Ishunina T A, Swaab D F, Fischer D F. Estrogen receptor-α splice variants in the medial mamillary nucleus of Alzheimer's disease patients: identification of a novel MB1 isoform. J Clin Endocrinol Metab 2005; 90: 3757–3765
- Koehorst S G, Cox J J, Donker G H, Lopes da Silva S, Burbach J P, Thijssen J H, Blankenstein M A. Functional analysis of an alternatively spliced estrogen receptor lacking exon 4 isolated from MCF-7 breast cancer cells and meningioma tissue. Mol Cell Endocrinol 1994; 101: 237–245
- Karas R H, Baur W E, van Eickles M, Mendelsohn M E. Human vascular smooth muscle cells express an estrogen receptor isoform. FEBS Lett 1995; 377: 103–108
- Park W, Choi J J, Hwang E S, Lee J H. Identification of a variant estrogen receptor lacking exon 4 and its coexpression with wild type estrogen receptor in ovarian carcinomas. Clin Cancer Res 1996; 2: 2029–2035
- Pasqualini C, Guivarc'h D, Barnier J-V, Guibert B, Vincent J-D, Vernier P. Differential subcellular distribution and transcriptional activity of ΣE3, ΣE4, and ΣE3-4 isoforms of the rat estrogen receptor-α. Mol Endocrinol 2001; 15: 894–908
- Rice L W, Jazaeri A A, Shupnik M A. Estrogen receptor mRNA splice variants in pre- and postmenopausal human endometrium and endometrial carcinoma. Gynecol Oncol 1997; 65: 149–157
- Shupnik M A, Pitt L K, Soh A Y, Anderson A, Lopes M B, Laws E R, Jr. Selective expression of estrogen receptor α and β isoforms in human pituitary tumors. J Clin Endocrinol Metab 1998; 83: 3965–3972
- Hol E M, Roelofs R F, Moraal E, Sonnemans M A, Sluijs J A, Proper E A, de Graan P N, Fischer D F, van Leeuwen F W. Neuronal expression of GFAP in patients with Alzheimer pathology and identification of novel GFAP splice forms. Mol Psychiatry 2003; 8: 786–796
- Ishunina T A, Swaab D F. Age-dependent ERα MB1 splice variant expression in discrete areas of the human brain. Neurobiol Aging Mar 15, 2007, [Epub ahead of print]
- Fasco M J, Keyomarsi K, Arcaro K F, Gierthy J F. Expression of an estrogen receptor α variant protein in cell lines and tumors. Mol Cell Endocrinol 2000; 166: 156–169
- Denger S, Reid G, Kos M, Flouriot G, Parsch D, Brand H, Korach K S, Sonntag-Buck V, Gannon F. ERα gene expression in human primary osteoblasts: evidence for the expression of two receptor proteins. Mol Endocrinol 2001; 15: 2064–2077
- Figtree G A, McDonald D, Watkins H, Channon K M. Truncated estrogen receptor α 46-kDa isoform in human endothelial cells. Relationship to acute activation of nitric oxide synthase. Circulation 2003; 107: 120–126
- Barraille P, Chinestra P, Bayard F, Faye J-C. Alternative initiation of translation accounts for a 67/45 kDa dimorphism of the human estrogen receptor ERα. Biochem Biophys Res Commun 1999; 257: 84–88
- Flouriot G, Brand H, Denger S, Metivier R, Kos M, Reid G, Sonntag-Buck V, Gannon F. Identification of a new isoform of the human estrogen receptor-α (hER-α) that is encoded by distinct transcripts and that is able to repress hER-α activation function 1. EMBO J 2000; 19: 4688–4700